Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer
Annals of Surgical Oncology, 05/11/2012Fong D et al.
These findings suggest for the first time that low levels of JAM–A expression in pancreatic cancer are associated with poor clinical outcome. JAM–A may represents a target molecule for functional inactivation and serve as a novel biomarker of adverse prognosis in pancreatic cancer.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.